Skip to content

Hemofiltration Catheter HF-100

by Vas-Cath of Canada, Ltd.

510(k) K840322

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK840322 Date24 Apr 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FIQ
FDA applicant
Vas-Cath of Canada , Ltd.
Device Class
Class II
Regulation
21 CFR Part 876.5540
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Hemofiltration Catheter HF-100 is a cannula intended for arteriovenous shunt applications in hemofiltration procedures. It provides vascular access to enable extracorporeal blood purification in gastroenterology and urology settings.

The device was cleared by the U.S. FDA through a 510(k) submission (K840322) as substantially equivalent, classified as Class II under product code FIQ and regulation 876.5540. It is manufactured by Vas‑Cath of Canada, Ltd. and distributed in the United States. No additional information on sterility, single‑use or reuse is provided in the source data.

Other devices from Vas-Cath of Canada, Ltd.

See all devices from Vas-Cath of Canada, Ltd. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical applications is the HF-100 designed for?

    The HF-100 is intended to provide vascular access for arteriovenous shunt applications during hemofiltration procedures. It is specifically listed for use in gastroenterology and urology settings, where extracorporeal blood purification is required.

  • How is the HF-100 supplied and what is known about its sterility?

    The source data does not specify packaging details or sterility status. Because sterility information is absent, purchasers should request the manufacturer’s labeling or packaging insert to confirm whether the catheter is supplied sterile and under what conditions.

  • Is the HF-100 a single‑use or reusable device?

    The provided information does not indicate whether the catheter is intended for single‑use or multiple uses. In the absence of explicit guidance, clinicians should follow standard institutional policies and seek clarification from Vas‑Cath of Canada regarding reuse recommendations.

  • Are there multiple sizes or models of the HF-100 available?

    The device description only references the HF-100 model without mentioning alternative sizes or variants. Therefore, no additional size or model options can be confirmed from the available data.

  • What regulatory clearance does the HF-100 have?

    The HF-100 received traditional 510(k) clearance (K840322) from the U.S. FDA, classified as a Class II device under product code FIQ and regulation 876.5540. This indicates it was found substantially equivalent to a predicate device.